HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dominik Pretscher Selected Research

tafasitamab

11/2022Tafasitamab mediates killing of B-cell non-Hodgkin's lymphoma in combination with γδ T cell or allogeneic NK cell therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dominik Pretscher Research Topics

Disease

4Neoplasms (Cancer)
11/2022 - 01/2018
3Lymphoma (Lymphomas)
11/2019 - 06/2017
1Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2022
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2022
1B-Cell Lymphoma (Lymphoma, B Cell)
11/2019
1Epstein-Barr Virus Infections
03/2018
1Autoimmune Hepatitis
03/2018
1Plasmablastic Lymphoma
06/2017

Drug/Important Bio-Agent (IBA)

2Monoclonal AntibodiesIBA
11/2022 - 11/2019
2Lenalidomide (CC 5013)FDA Link
11/2022 - 06/2017
1Surface Antigens (Surface Antigen)IBA
11/2022
1tafasitamabIBA
11/2022
1Rituximab (Mabthera)FDA Link
11/2019
1ElementsIBA
11/2019
1Immunoglobulins (Immunoglobulin)IBA
11/2019
1daratumumabIBA
11/2019
1obinutuzumabIBA
11/2019
1AntibodiesIBA
11/2019
1Neoplasm Antigens (Tumor Antigens)IBA
11/2019
1Fc Receptors (Fc Receptor)IBA
11/2019
1Azathioprine (Imuran)FDA LinkGeneric
03/2018
1Immunosuppressive Agents (Immunosuppressants)IBA
03/2018
1Immune Checkpoint ProteinsIBA
01/2018
1Brentuximab VedotinIBA
06/2017

Therapy/Procedure

5Therapeutics
11/2022 - 06/2017
2Immunotherapy
11/2019 - 01/2018
1Drug Therapy (Chemotherapy)
06/2017